Additional examples include miR-212, which modulates EZH2, G9a, and HDACs in lung cancer; miR-126, targeting HDAC2 in prostate cancer; and miR-34a, which regulates SIRT1 in breast cancer. Here, EZH2 is linked to breast carcinoma.